Detailansicht

Wissensnetz

Person

Bogdana Suchorska (1983-)

Ärztin

Name	Bogdana Suchorska
Zeit	1983- (Lebensdaten)
Ort	Lemberg (Geburtsort) Ukraine Deutschland
Geschlecht	weiblich
Beruf	Ärztin (charakteristischer Beruf)
Weitere Angaben	Diss. Fachbereich Medizin. - Habilitationsschrift, Medizinische Fakultät, Ludwig-Maximilians-Universität München, 2018
Datensatztyp	Person
GND-Nummer	140486887
Datensatz-ID	140486887
Beteiligt an alle anzeigen Combination of pre-treatment dynamic [18F]FET PET radiomics and conventional clinical parameters for the survival stratification in patients with IDH-wildtype glioblastoma Can Radiomics Provide Additional Information in [F-18]FET-Negative Gliomas? L-type amino acid transporter (LAT) 1 expression in 18F-FET-negative gliomas Prediction of TERTp-mutation status in IDH-wildtype high-grade gliomas using pre-treatment dynamic [18F]FET PET radiomics TERT-Promoter Mutational Status in Glioblastoma – Is There an Association With Amino Acid Uptake on Dynamic 18F-FET PET? Non-invasive prediction of IDH-wildtype genotype in gliomas using dynamic 18F-FET PET Voxel-wise analysis of dynamic 18F-FET PET: a novel approach for non-invasive glioma characterisation 18F-FET-PET as a biomarker for therapy response in non-contrast enhancing glioma following chemotherapy Einsatz moderner bildgebender Verfahren und individualisierter Therapiekonzepte in der Neuroonkologie O-(2-[18F]fluoroethyl)-l-tyrosine PET in gliomas: influence of data processing in different centres Towards standardization of 18F-FET PET imaging: do we need a consistent method of background activity assessment? O-(2-[18F]fluoroethyl)-L-tyrosine PET in gliomas: influence of data processing in different centres Usefulness of PET Imaging to Guide Treatment Options in Gliomas Early static 18F-FET-PET scans have a higher accuracy for glioma grading than the standard 20–40 min scans Symptomatic cavernous malformations of the brainstem: functional outcome after microsurgical resection Wertigkeit des Apparent Diffusion Coefficient (ADC) und der fraktionalen Anisotropie (FA) für die Differenzierung der cortikobasalen Degeneration vom idiopathischen Morbus Parkinson

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Bogdana Suchorska (1983-)

Combination of pre-treatment dynamic [18F]FET PET radiomics and conventional clinical parameters for the survival stratification in patients with IDH-wildtype glioblastoma

Can Radiomics Provide Additional Information in [F-18]FET-Negative Gliomas?

L-type amino acid transporter (LAT) 1 expression in 18F-FET-negative gliomas

Prediction of TERTp-mutation status in IDH-wildtype high-grade gliomas using pre-treatment dynamic [18F]FET PET radiomics

TERT-Promoter Mutational Status in Glioblastoma – Is There an Association With Amino Acid Uptake on Dynamic 18F-FET PET?

Non-invasive prediction of IDH-wildtype genotype in gliomas using dynamic 18F-FET PET

Voxel-wise analysis of dynamic 18F-FET PET: a novel approach for non-invasive glioma characterisation

18F-FET-PET as a biomarker for therapy response in non-contrast enhancing glioma following chemotherapy

Einsatz moderner bildgebender Verfahren und individualisierter Therapiekonzepte in der Neuroonkologie

O-(2-[18F]fluoroethyl)-l-tyrosine PET in gliomas: influence of data processing in different centres

Towards standardization of 18F-FET PET imaging: do we need a consistent method of background activity assessment?

O-(2-[18F]fluoroethyl)-L-tyrosine PET in gliomas: influence of data processing in different centres

Usefulness of PET Imaging to Guide Treatment Options in Gliomas

Early static 18F-FET-PET scans have a higher accuracy for glioma grading than the standard 20–40 min scans

Symptomatic cavernous malformations of the brainstem: functional outcome after microsurgical resection

Wertigkeit des Apparent Diffusion Coefficient (ADC) und der fraktionalen Anisotropie (FA) für die Differenzierung der cortikobasalen Degeneration vom idiopathischen Morbus Parkinson